<!doctype html>
<html lang="en">

<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">

  <link
    crossorigin="anonymous"
    href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap/5.1.3/css/bootstrap.min.css"
    integrity="sha512-GQGU0fMMi238uA+a/bdWJfpUGKUkBdgfFdgBm72SUQ6BeyWjoY/ton0tEjH+OSH9iP4Dfh+7HM0I9f5eR0L/4w=="
    referrerpolicy="no-referrer"
    rel="stylesheet"
  />
  <link rel="stylesheet" href="./static/css/oxford.css">
  <link rel="stylesheet" href="./static/css/outliers.css">

  <title>Static outliers for NHS Newcastle Gateshead CCG</title>
</head>
<body>
    <div class="bg-dark">
      <div class="container d-flex justify-content-center">
        <a class="visually-hidden-focusable text-white p-2" href="#content">Skip to main content</a>
      </div>
    </div>

    <header>
      <nav class="navbar navbar-expand-lg navbar-dark bg-dark bg-oxford">
        <div class="container">
          <a class="navbar-brand" href="../index.html">OpenPrescribing outlier detection</a>
        </div>
      </nav>
    </header>

    <main id="content">
      <div class="bg-oxford-50 mb-4">
        <div class="container pt-5 pb-4">
          <div class="row">
            <div class="col-12">
              <h1 class="display-5 fw-bold lh-1">Static outliers for NHS Newcastle Gateshead CCG</h1>
            </div>
            <div class="col-lg-8 col-md-9 col-12 pt-4 fs-5">
              <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
                explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support
                prescribers and organisations to audit and review prescribing.</p>
              <p>This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical
                  in the <a href="https://www.thedatalab.org/blog/161/prescribing-data-bnf-codes">BNF coding system</a> using the BNF subparagraph as a denominator, for prescriptions dispensed between April 2021 and August 2021. We then calculate the
                  mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs/STPs. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given practice/CCG/PCN/STP is from the
                  population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.
              </p>
              <p>It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where
                  it might not. Our full analytical method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a>.
              </p>
              <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=ccg+13T">survey</a>            or emailing us at <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can
                  send short or detailed feedback.
              </p>
            </div>
          </div>
        </div>
      </div>
    </main>

    <section aria-labelledby="higherHeading">
      <div class="container">
        <h2 class="pb-3" id="higherHeading">Prescribing where NHS Newcastle Gateshead CCG is higher than most</h2>
      </div>
      <div class="container px-lg-4 mb-4">
        <div class="table-responsive">
          <table border="1" class="dataframe table table table-sm table-bordered" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Standard Deviation">std</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr class="low_number row_1">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0604030L0&amp;denomIds=6.4.3&amp;selectedTab=summary">Nandrolone decanoate</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_0_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>3</td>
      <td>Anabolic steroids</td>
      <td>3</td>
      <td>1.00</td>
      <td>0.02</td>
      <td>0.12</td>
      <td>8.54</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_w6qNNJ0CaEVGC2o1GBaXYoVSbHFxoaM"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_w6qNNJ0CaEVGC2o1GBaXYoVSbHFxoaM" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAg0AAACWCAYAAABdJrs9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAXEQAAFxEByibzPwAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAANFElEQVR4nO3df6wl5V3H8fcXdpcfu6X+AElTtBMLoUCtECkQVCi2NK1DGgoINrWhkWr6w6qNNJ0C/aEVGC2o1GBaXYoVSbHFxoaMKSi2EBClTVuXX0IBp2VlVWxrFVi67O7jH2fu5e7l7t5nYc+ZO+e8X8nknDn3We5nn5yd8+GZc+ZESglJkqTl7NV3AEmSNAyWBkmSlMXSIEmSslgaJElSFkuDJEnKYmmQJElZLA2SJCmLpUGSJGWxNEiSpCyWBkmSlMXSIEmSslgaJElSFkuDJEnKYmmQJElZLA2SJCmLpUGSJGWxNEiSpCyWBkmSlMXSIEmSslgaJElSFkuDJEnKYmmQJElZLA2SJO1KxFoiUret7TtOnywNkiQpy6o+f3lRNZcBnwPuaOsy9ZlFkiTtWqTU32t1UTVzv/w+YD1wTVuXj/UWSJKkxUanJB7v9taR0hN9xulT36cnfg24EzgCuBz496Jq3t9vJEmStJReVxrmFFXzE8B5wNuAtcAFbV1e2m8qSZJwpWGBFVEa5hRVcyJwI7AOOL+ty8t7jiRJmnWWhnl9n57YQVuX/wiUwJPAZUXVvLvnSJIkqbOiSgNAW5e3Am8AngI+VlTN23uOJEmSWIGlAaCty5uB04EtwJVF1RzXcyRJkmbeiiwNAG1d3sjo0xV7AVcVVbOm50iSJM20FVsaOuuBLwIvB6qes0iSNNNW1KcnllJUzUuBuxhdvfKYti7v6TmSJGmW+OmJeSt9pYG2Lh8CPgCsBtYXVbN3z5EkSZpJK740dK4AvgycwOh9DpIkacJW/OmJOd1VI7/K6BMVL2/r8t96jiRJmgWenpg3lJUG2rq8C7gU2L+7lSRJEzSY0tCpgU3AOUXVHNN3GEmSZsmgSkNbl08CH+l2L+4ziyRJs2ZQpaFzFfAw8Pqian627zCSJM2KwZWGti63AB/sdi8tqib6zCNJ0qwYXGnoXAfcDfw08PM9Z5EkaSYMsjS0dbkNuLDbvbiomkH+PSRJGpIhv9jeANwB/CRwTs9ZJEmaeoMtDW1dJuCCbvd3iqpZ1WceSZKm3WBLA0Bbl18CbgYOBc7uN40kSdNt0KWhM3fdhgt9b4MkSeMzDS+ytwK3AUcCb+w5iyRJU2vwpaF7b8PvdrsXed0GSZLGY/CloXMTo6/OPhooe84iSdJUmorS4GqDJEnjNxWloXMD8C/A8cBres4iSdLUmZrS0K02zH3z5UV9ZpEkaRpNTWno/DVwH3BSUTUn9R1GkqRpMlWloa3L7cAl3a6rDZIk7UFTVRo61wEPAacWVXN832EkSZoWU1ca2rrcClza7braIEnSHjJ1paFzDfAt4LSiao7pO4wkSdNgKktDW5dbgN/rdi/sM4skSdNiKktD55PAJuDMomqO6juMJElDN7Wloa3Lp4CPdrsX9JlFkqRpMLWlofOnwGPALxZVc1jfYSRJGrKpLg1tXT4B/AGjv6fvbZAk6XmY6tLQuRL4NvCWomqO7DuMJElDNfWloa3L/2N03Ya9gI/0HEeSpMGa+tLQ+RNgI3BGUTWv7DuMJElDNBOloa3LzcBvd7uX7GqsJEla2kyUhs6fAw8Arymq5tU9Z5EkaXBmpjR030nxgW73kqJqos88kiQNzcyUhs71wNeA44DTe84iSdKgzFRpaOtyO89cHfLiompW9ZlHkqQhmanS0LkRuAU4Anhnz1kkSRqMSCn1nWHiiqp5BfBV4Eng8LYuN/UcSZK0UkWsBR7v9taR0hN9xunTLK400NblBuAK4AXA5T3HkSRpEGayNHQ+DDwKvMmPYEqStLyZLQ3d5aV/s9u9sqiaffrMI0nSSjezpaFzPXATcDjwWz1nkSRpRZvJN0IuVFTNYcDdwDbgyLYu234TSZJWFN8IOW/WVxpo6/IbQA3sB3zKazdIkrS0mS8NnUsYXSnyJOBDPWeRJGlFmvnTE3OKqjmU0bUb1gGvbevy73uOJElaCTw9Mc+Vhk5blw8CvwIEcG1RNS/qOZIkSSuKpWGBti7/CvgE8COMisPePUeSJGnFsDQ823uADcApPPNV2pIkzTxLwyJtXW4GzmZ0/upDRdX8as+RJElaESwNS2jr8n7gTGAL8PGias7tOZIkSb2zNOxEW5c3AWcxuujTJ4uqOafnSJIk9crSsAttXd4AvKnbvbaomjf2mUeSpD55nYYMRdW8GbgG2Aq8Hbi6rUsnTpJmgddpmOdKQ4a2Lq8FzmM0X1cBVxdVs7bfVJIkTZalIVNbl1cDrwIeBc4F/rmomiN6DSVJ0gR5emI3FVVzEPCXwGuBJ4D3Auvbuny612CSpPHw9MQ8S8Nz0F0p8gLgw4xWa74BfBD4TFuX23uMJkna0ywN8ywNz0NRNccy+obMU7uHNjAqD01bl1t7CyZJ2nMsDfMsDXtAUTWnMCoPJ3QPPQZcD3wauN3VB0kaMEvDPEvDHlJUTQCnAe9gtPKwqvvRRuBm4J+67W5XISRpQCwN8ywNY1BUzYHAGYwuDHUyo6/bnvMkcBfw8IKtBf6T0QrFdywVkrSCWBrmWRrGrPu0xfHddgJwHHDALv5IAr4LfI/Rk/SJBbeL728Gvg881d0uvJ/1mAVF0rQoqmYvYDWwJmNbbtzec//dgx7/7povX/mW3wc49l3XvO+/1/3glu5H24CnF2xbF+0vtW1ZtH1/wf2nV/rpbEvDhHVP6hcDP75gK4CDgAO77SBg/wlF2sbyJWNLN27rotvdvT/3jyGN8XZnP8sRyw/Z7bF9jevzd09Txmn6u/T5u4PRi/CqRdvq3XxsNbt+sZ87LbxH7bflKe77w7MAOOI917N5zb7j+DVztrJjkViqXCz12FZGx9jtwPa2Lt86jnBjmWDtXNciH+m2W3Y2rqiaVcDablu3xP11wL7APgtud3Y/97EXMPoHKUkrXeKZF80ngf/p7i/1f/O7u82tGgCw9unNa4AaYO2Wze/bvGbfLTxThFYv2lYt8djiba7k7MOzi8/Cx/bv9p+Ltz7HP7dLva00RMQ9ACmlo3oJMKWc1z3POR0P53U8nNfxcF5HvIy0JEnKYmmQJElZLA2SJCmLpUGSJGWxNEiSpCyWBkmSlMWLO0mSpCyuNEiSpCyWBkmSlMXSIEmSslgaJElSFkuDJEnKYmmQJElZxl4aIuJVEXFPRDwYEesjYu8lxpwdEQ9ExEMRcfG4M02D5eY1Io6OiNu7MXdHxK/3lXVIcp6vC8Y2EfHgJPMNVeZx4OCI+HxE/GtE3B8Rp/WRdSgy5/T8bsyGiPhCRBzcR9YhiYgrImJjRGzdxZjs48S0GWtpiIi9gPXAL6SUDgUOAH5p0ZgXApcBJwOHA6dExMnjzDV0OfPK6Pvlf7n7GtcTgXdHxNGTTTosmfM6N/bNwHcmGG+wdmNePwVcm1J6GXAUcMfkUg5L5rH1MOAdwLEppVcAXwfOn3TWAfoscOzOfrg7x4lpNO6VhlcCj6aU7u32rwLOXDTmdcCXUkqbUkpbGR04Fo/Rjpad15TSAyml+7v7/wvcB/zoRFMOT87zlYg4EHgX4KpYnmXnNSIOBw5OKX0GIKW0NaX07cnGHJSc52oAq4H9IiIYvbhtmlzEYUop3ZZS+o9dDMk6TkyrcZeGQ4BHFux/i2e/cOWM0Y52a84i4qWMmvPtY841dLnz+kfARcBTkwg1BXLm9WXAf0XEpyPiaxHxFxHxQxNLODzLzmlK6QHgj7txmxit3lwxqYBTbKZfs8ZdGmIPjdGOsucsIn4A+BvgN1JKLqfv2rLzGhGvB7allP5hAnmmRc7zdRVwEnBxSukYoAU+Os5QA5fzXP1h4AzgUODFwMPAe8ecaxbM9GvWuEvDI+zYwH4M2PgcxmhHWXMWEfsDDfBnKaXPTijbkOXM60nAqyOiBW4DXhIRGyYTb7ByjwP3ppTu7vavA35qAtmGKmdOfw54uDv1u43RufoTJ5Rvms30a9a4S8NXgEMi4shu/zzgc4vGfIHRmx9fFBGrgHOXGKMdLTuvEbG6e+zvUkofm3C+oVp2XlNK708pHZJSKoCfAb7ZvclMO5dzHPgKsCYi5g7GpwL3TCjfEOXM6TeB4yPigG7/VOBe9HzlzP3UGmtp6Nrt24DrI+Ih4HHgmoh4Q0Ss78Z8j9GS2a3A/cAtKaUvjjPX0OXMK3A2o4PE6RHx9W47q6fIg5A5r9pNmceB7cA7gc93Kzevw3f671TmnN7J6I3ld0bEXcBLgLqvzEMREZ+IiI3A3t1HL6+MiGMj4m9h53PfY+SJ8quxJUlSFq8IKUmSslgaJElSFkuDJEnKYmmQJElZLA2SJCmLpUGSJGWxNEiSpCyWBkmSlMXSIEmSslgaJElSFkuDJEnKYmmQJElZLA2SJCmLpUGSJGWxNEiSpCyWBkmSlMXSIEmSslgaJElSFkuDJEnKYmmQJElZLA2SJCmLpUGSJGWxNEiSpCyWBkmSlOX/Af5K/wBQ1q8HAAAAAElFTkSuQmCC"></div></div></div></div></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0604030L0BBABAB&amp;denomIds=6.4.3&amp;selectedTab=summary" target="_blank">Deca-Durabolin 50mg/1ml solution for injection ampoules : 3</a></li></ul></td></tr><tr class="low_number row_2">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0801050AA&amp;denomIds=8.1.5&amp;selectedTab=summary">Imatinib mesilate</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_1_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>1</td>
      <td>Other antineoplastic drugs</td>
      <td>15</td>
      <td>0.07</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>8.37</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_vBWcAkkJogwWXAzGGwirNFWoungIKHE"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_vBWcAkkJogwWXAzGGwirNFWoungIKHE" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0801050AAAAABAB&amp;denomIds=8.1.5&amp;selectedTab=summary" target="_blank">Imatinib 400mg tablets : 1</a></li></ul></td></tr><tr class="low_number row_3">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0605010T0&amp;denomIds=6.5.1&amp;selectedTab=summary">Tetracosactide</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_2_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>1</td>
      <td>Hypothalamic &amp; anterior pituitary hormone &amp; antioestrogens</td>
      <td>5</td>
      <td>0.20</td>
      <td>0.01</td>
      <td>0.02</td>
      <td>8.26</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_KImhBQqIlcXRICQCgkJMhGChGLGiTbh4"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_KImhBQqIlcXRICQCgkJMhGChGLGiTbh4" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0605010T0AAAAAA&amp;denomIds=6.5.1&amp;selectedTab=summary" target="_blank">Tetracosactide 250micrograms/1ml inj ampoules : 1</a></li></ul></td></tr><tr class="row_4">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=1303000B0&amp;denomIds=13.3&amp;selectedTab=summary">Benzocaine</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_3_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>8</td>
      <td>Topical local anaesthetics and antipruritics</td>
      <td>923</td>
      <td>0.01</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>6.95</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_QYEHRmUKyQNIyI8yFXKCcSTUHUxPQJmW"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_QYEHRmUKyQNIyI8yFXKCcSTUHUxPQJmW" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAg0AAACWCAYAAABdJrs9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAXEQAAFxEByibzPwAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAOXklEQVR4nO3df7BndV3H8eeH3cvusssCUjAk4FEIRaaGBklrECvClNOgiYNWOjRCE42BQYEHRmUKyQNIyI8yFXKCcSTUHUxPQJmWo/0woIbfvzsCSRJYIcsucO+e/jjn3v3u3fvj3Lv3fD/fH8/HzGfOz++X9+Gz3+/3dT/f8z0nVFWFJEnSYnaLXYAkSRoOhgZJktSKoUGSJLViaJAkSa0YGiRJUiuGBkmS1IqhQZIktWJokCRJrRgaJElSK4YGSZLUiqFBkiS1YmiQJEmtGBokSVIrhgZJktSKoUGSJLViaJAkSa0YGiRJUiuGBkmS1IqhQZIktWJokCRJrRgaJElSK4YGSZLUiqFBkqSFhLCeEKqmrY9dTkyGBkmS1Mrq2AXMJ8mKq4AXmnYP8Jdlnk7FrUqSpPEVqqqKXcOckqyYXdidwNllnv5djHokSWOq/kriuWZpA1W1OWY5MQ1yaDgRWAPsAZwGHNNs+ipwTpmn98eqTZI0RgwNMwY2NPRKsiIAJwGXAK8EJoHTyzy9NmphkqTRZ2iYMRShYVqSFWuBM4GPUp+P8d4yTz8XtypJ0kgzNMwYqtAwLcmKtwNfbBbfVebpl2LWI0kaYYaGGUP5k8syT28C3kNd/+eTrDghckmSJI28oQwNAGWe3gCcCkwAm5KsOC5ySZIkjbShDQ0AZZ5+Fng/9a8sNiVZkcStSJKk0TXUoQGgzNM/BS4GNgLXJVmxKnJJkiSNpKEPDY2PAHcAbwQ+GLkWSZJG0lD+emIuSVa8hjo4TAA/U+bpbZFLkiSNAn89MWNURhporhB5NvX1Gz6XZMVY34lMkqSVNjKhofEp6stMHwZcFrkWSZJGysh8PTEtyYr9gLuA/YATyjy9OXJJkqRh5tcTM0ZtpIEyT58CfrNZvLq59LQkSdpFIxcaAMo8/SvgK8CrgHMjlyNJ0kgYydDQ+ACwFTgvyYpXxi5GkqRhN7KhoczT/wByYC3wicjlSJI09EY2NDQuAR4FTkyyIo1djCRJw2ykQ0OZp1uAM5vFKz0pUpKk5Rvp0ABQ5mnB9pMivcS0JEnLNPKhoTF9UuQHk6w4KHYxkiQNo7EIDc1JkZcB64CLIpcjSdJQGovQ0LgY+D7w3iQrjo5djCRJw2ZsQkOZpz8EPtQs/nGSFSFmPZIkDZuxCQ2Nz1Lfl+IY4B2Ra5EkaaiMVWgo83SK+vbZAJckWbEmZj2SJA2TsQoNAGWefg0oqH+C+TuRy5EkaWiMXWhonANMAR9OsuJHYxcjSdIwGMvQUObpfcAngb2ACyKXI0nSUBjL0ND4A+D/gNOTrDg8djGSJA26sQ0NZZ4+DVwIrAIujVyOJEkDb2xDQ+Nq6rtgpklWHB+7GEmSBtlYh4YyT18Azm0WL0uyYlXMeiRJGmRjHRoam4BvAT8BvC9yLZIkDaxQVVXsGqJr7kXxHeAp4NDmktOSJEEI64HnmqUNVNXmmOXE5EgDUObpvwLXA/sB50UuR5KkgWRo2O58YAvwe0lWHBq7GEmSBo2hoVHm6RPARcDuwJXeBVOSpB0ZGnb0ceAh4K3A2yLXIknSQDE09Gh+gnlGs3hFkhXrY9YjSdIgMTTMUubprcCXgIOpz3OQJEkYGuZzFvA8cE6SFYfFLkaSpEFgaJhDmaePA38ITABXeVKkJEmGhoVcDjwAvBn41ci1SJIUnaFhHmWevgj8VrN4dZIVPxazHkmSYjM0LKDM038ArgD2AT7t1xSSpHFmaFjc+dTXbkiB34hbiiRJ8RgaFlHm6fPAKcA26ms3HBy5JEmSojA0tFDm6T9RXy1yT+Bav6aQJI0jQ0N7FwD3AL8I/HbkWiRJ6jtDQ0tlnm6l/ppiErg8yYqfjlySJEl9ZWhYgjJPbwfOpr4T5qYkK/aPXJIkSX1jaFi6q4HrgJcDNyZZMRG5HkmS+sLQsERlnlbA6cAdwLHAZXErkiSpPwwNy1Dm6RbgV4CngTOSrDglckmSJHXO0LBMZZ4+BpwMTAGfSrLiTZFLkiSpU4aGXVDm6TeA3wXWAEWSFcdELkmSpM4YGnZRmadXA+cB64Gbk6x4Q+SSJEnqhKFhBZR5mgMfATYAtyZZcXTkkiRJWnGGhhVS5umFwIXARuBvkqw4KnJJkiStKEPDyroAyIG9gW8mWfGuyPVIkrRiQlVVsWsYKc3NrM4FPgYE4FLg/DJPJ6MWJklanhDWA881Sxuoqs0xy4nJ0NCRJCt+CbiBetTha8C7yzx9Jm5VkqQlMzTM8OuJjpR5eivwOuBu6jtj3p5kxVviViVJ0vI50tCxJCs2ANcA0+c3bALOai4OJUkadI40zDA09EFznsOJwBXAK4DnqX9pcXmZpy/ErE2StAhDwwxDQx8lWbEHcD5wDvXttf8L+BPgz8o8fTpmbZKkeRgaZhgaIkiy4jDgYuBt1L+w2ApcT33b7buaO2lKkgaBoWGGoSGiJCsOBc4A3kd9NUmAB4EvAzcB/1zm6bZI5UmSwNDQw9AwAJKs2Bs4FXgPcGTPpu8D3wT+BfgOcHuZp8/3v0JJGmOGhhmGhgGTZEVCfdLk24FjgVU9m6eA+4GHe9ojwPeoA8YPBmFkIsmKCWBtT1u3xPm11Od8TKuaxqzpFPVXO1vmmE7Pbwb+t6dt9esfSUtiaJhhaBhgSVZsBI4CXt/TDljgIVPAfwPPUP8D/2HTNgMvNdun2+Ss5W3AamBinraa+oO8TRjoDTqD5kV2DBHztf+Za1rm6YsRapYUk6FhhqFhyCRZ8TLgEODQph0C7N/T9qP+gO+nip3/2t86x/JS5l9qnjc0jTmmq9kxsKybY34DsBf1lTmn2z7UQWg5nmeeQAE8S/3GsnlW6123hTq49LYXBmGESNI8DA0zDA0jprkmxAZgz1nT1dQjAL2td91u1KMPL83RetfPFQ5eGqYh/+b/0Vp2DBK9wWKfRaZ7s/KjKVNsDxGT1IFp2xxtvvWLbZurTbXcr/ffwouzpm3me6e9ba51M9sMUloJzet99aw2schy77rwqmeeWPP1a06/GeC40z755kf2PWgL219v1Rxt+vU1e1R39gjvnNsG+f3U0CAtUfMmtCc7B4rpgLa+p22YNb+G+mue6enstobtIS400942TnqDVKug0TPt/dptudPpD4Rps8+raTO/0vvC/CNvi0135bHLfY7d2PkPlIX+eFlo+0If7At9+O9ywF/34lbuu/ydABx+1hfZsvvaXX3KxcwXOhYKITvMl3n6hi4K6/cwtjT0mr8Cnm1aXy8H3gSW+QJF7/pVC+yzap718+07fT7LRM90vvk222e3+db3btvQTAf5fBnFs43tI6KT1COgk7PWTS5j3SRQTWybnAB+DWBi2+QNW+r/3vRXp7v1zPeumy8YLXV+ennNrG29Qa5vBnKkIYRwD0BVVUfErmVc2QeDwX6Izz4YDPbDYBi34U5JkrRMhgZJktSKoUGSJLViaJAkSa0YGiRJUiuGBkmS1MpA/uRSkiQNHkcaJElSK4YGSZLUiqFBkiS1YmiQJEmtGBokSVIrhgZJktRKX0JDCOHnQgj3hBAeDiFcE0LY6fa2IYSTQwgPhhAeCSFc1LN+YwjhKyGEh0IIt4UQDl/sMdpZF30QQjgyhPDt5nnvDiGc2c9jGkZdvRZ69ilCCA93fRzDrMP3o/1DCF8OIdwfQngghPDL/TqmYdRhP/x+87x3hhBuCSHs369jGgtVVXXaqIPJw8Brm+UbgVNm7bMX8BhwAPW9wv8ReFOz7aPAHzXzJwDfWOwxtr71wWHAq5v5jcBDwJGxj3dQW1f90PPYXweuBx6OfayD2rrsA+AW4ORmfjWwb+zjHdTW4XvSjwOPAOua5Ry4NPbxjlLrx0jD0cD3qqq6t1m+Fjhp1j5vAf6+qqonq6qaBP6iZ5+TgGsAqqr6a+CwEMK+izxGO+qkD6qqerCqqgea9c8C9wEHdXsoQ62r1wIhhB8B3g844rawTvoghPBqYP+qqm5stk1WVfVMx8cyzLp6LQRgAlgXQgjUf8w82emRjJl+hIYDgcd7lh9j5w+WhfaZve2JZl2b51Wtqz6YEUI4BHgd8O0VqHdUddkPnwA+BGxdqWJHVFd98BrgqRDC50MI/xZCuC6E8LIVrXy0dNIPVVU9CFzVbHsSOAK4YuXKVj9CQ1ihfVbiMeOqqz6oHxjC3sBNwAeqqvrBcp9nDHTSDyGEtwJTVVV9fekljZ2uXgurgWOBi6qq+imgBC5dxvOMi65eC/sC7wAOBV4OPAqcs9Tn0fz6ERoeZ8cEeTB1Kmy7zxOzth0I/GfL51Wtqz4ghLAHUACfqarqCytY8yjqqh+OBY4LIZTAt4BXhBDuXLmyR0qX70f3VlV1d7P+BuCoFap5FHXVD78APNp8pTEFfAH42RWse+z1IzTcBhwYQnhts3wqsGnWPrcAPx9COCCEsBo4pWefTcBpACGEE6hP8np6kcdoR530QQhhotn2t1VVXdn1QYyATvqhqqrzqqo6sKqqBDgG+G5VVT/Z8bEMq67ej24Ddg8hTH+QHQ/c091hDL2u+uG7wOtDCBub/Y4H7kUrpx9nW1Knv3upz2r9c+qhvBOBa3r2eTf12fePAB/rWb8X8NVm2x3AEYs9xtafPqA+W38K+Pee9s7YxzrIravXQs8+Cf56IkofAG9s1t0J3AwcEPtYB7l12A8fBu4H7qIOF3vHPtZRat4aW5IkteIVISVJUiuGBkmS1IqhQZIktWJokCRJrRgaJElSK4YGSZLUiqFBkiS1YmiQJEmtGBokSVIrhgZJktSKoUGSJLViaJAkSa0YGiRJUiuGBkmS1IqhQZIktWJokCRJrRgaJElSK4YGSZLUiqFBkiS1YmiQJEmtGBokSVIrhgZJktSKoUGSJLViaJAkSa38P99INRrifjJhAAAAAElFTkSuQmCC"></div></div></div></div></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=1303000B0AAAFAF&amp;denomIds=13.3&amp;selectedTab=summary" target="_blank">Benzocaine 3% cream : 8</a></li></ul></td></tr><tr class="row_5">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=1001030F0&amp;denomIds=10.1.3&amp;selectedTab=summary">Penicillamine</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_4_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>239</td>
      <td>Rheumatic disease suppressant drugs</td>
      <td>16286</td>
      <td>0.01</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>6.13</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_IepxKWNEQBENgoqJC6JRSUXcUFYxLAIy"><img width="250" class="h-auto" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAg0AAACWCAYAAABdJrs9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAXEQAAFxEByibzPwAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAS7UlEQVR4nO3debQkZXnH8e/LDIMwiOwEdKAEEdkMsqmgoKAxpgAVVNCQKEo06hGigpZHIepxKWNEQBENgoqJC6JRSUXcUFYxLAIywLBZAsIRBBEGgWHGyh9Vl+m53pmpurerq7vv93NOnd6q6z7PdE/f333rrepQFAWSJEmrs0bXBUiSpNFgaJAkSbUYGiRJUi2GBkmSVIuhQZIk1WJokCRJtRgaJElSLYYGSZJUi6FBkiTVYmiQJEm1GBokSVIthgZJklSLoUGSJNViaJAkSbUYGiRJUi2GBkmSVIuhQZIk1WJokCRJtRgaJElSLYYGSZJUi6FBkiTVYmiQJEm1GBokSbNTCPMJoaiW+V2XMwoMDZIkqZa5XRcwTKIkmw/sBDwT2BlYC/gjcH91eRdwfp7G93ZWpCRJHQlFUXRdQ6eiJNsMeBNwOLAtEFbzlAK4AvgB8EPg4jyNl7VapCSp/8pdEourW+tSFA91Wc4omLWhIUqy3YCjgMOAedXdOXBNz/Ig8CRg/epyW+BvgC17NnUz8O/AmXkaPzyI2iVJfWBoaGzWhYYoyRYAnwdeWt31AHA6cEqexrfUeH4AtgNeAhwM7FM9dDdwMnBqnsb39btuSVKfGRoamzWhofpl/zrgJGA94BbgBMoRgsWreu5qtrsHcCxwCOXE0vuB9wKnudtCkoaYoaGxWREaoiTbgnJ04QDKOQmfBI7L0/iRPv6MbYB3A0dShofLgbfkaXx5v36GJKmPDA2NjX1oiJLsecB3gQ2Bm4DX52l8SYs/b1fgVGBPyoDyOSDJ0/iBtn6mJGkaDA2NjfV5GqIkeznwI8rAcAqwS5uBASBP4yuB5wJvptxV8Rbgl1GSPafNnytJUtvGdqQhSrI3Uf7FH4Cj8zT+dAc1bEK5W+QVwDLgg8BHnesgSUPAkYbGxi40VBMejwc+ACwB/iFP47M6rudI4ERgHeAi4PA8jX/TVU2SJAwN0zBWoaH6Bf1vwDGU51h4eZ7G53VbVSlKsu2ArwK7AvcBr83T+AfdViVJs5ihobFxm9NwLGVguA/Yd1gCA0Cexoso5zqcSDnH4vtRkr0/SrJxew0kSWNqbEYaoiQ7AjgD+BOwX57Gv+i4pJWKkuwwyhNKrQOcA/xjnsb3d1uVJM0yjjQ0NhZ/5UZJdiBwGrAUOHiYAwNAnsZfpzwk8ybgQOCyKMl26LYqSZJWbeRDQ3UehrOAOcDrRmWeQJ7GC4E9gO8ATwMujZLsgG6rkiRp5UZ690SUZFtTnnlxA8rDKk/uuKTGqjkNxwP/SnkyqPcBaZ7Go/vCSNIocPdEYyMbGqIkmw/8HNgZOCFP43d1XNKMREl2CHAm5TyHrwNvzNP4T91WJUljzNDQ2EjunqgOrTyDMjD8BHhPtxXNXJ7G3wL2An5D+XXdF1bfyClJ0lAYydBAeVjlq4EcODRP46XdltMfeRpfTTnP4QLK8zlcFiXZXt1WJUlSaeRCQ5RkLwZS4GHgFXka39txSX2Vp/E9wIspv+hqM+BnUZK9oduqJEkasTkNUZJFwJWUEx9fm6fx17qtqF1Rkr0FOBmYW12+a1xGVSSpc85paGxkRhqiJFuTcoLgBpQTH8c6MADkaXwq8CLgXuAoyrNIbthtVZKk2WpkQgPwYeDZwKVA0nEtA5On8fnA7sA1lAHi/6Ik27HbqiRJs9FIhIYoyV4CvBv4I/CaPI0f67ikgcrTOAf2Br4FbEN5IqiDOi1KkjTrDP2chijJNgeuBjYBXlkdmjgrVSeCOo7ya7+L6vpHPRGUJE2DcxoaG+rQECXZHOCHwH7AqXkav7XjkoZClGQHU54Iaj7wDeANnghKkhoyNDQ27Lsn3kMZGK4B3tlxLUMjT+NvU54IKgcOBS6KkmzLTouSJI29oR1piJJsT+ASYAmwW57G13dc0tCJkmxj4GxgX+Bu4JA8jS/qtipJGhGONDQ2zCMN/0n5zZXvMDBMLU/j31OeCOqzwKbAeVGSHdltVZKkcTXMoWFb4HvAf3RdyDDL0/ixPI3fBvwzEIDToiQ7uTqvhSRJfTPMoeF3wJEeGVBPnsafB/YHfg+8HTg3SrKNuq1KkjROhjk0HFF9D4NqytP4AsovvLqacgLp5VGS7dZtVZKkcTG0EyE1fVGSzQe+CLyKciLp0cDnHbWRpB5OhGxsmEcaNE15Gj9EeSjm0ZSv8anAV6IkW7fTwiRJI82RhjEXJdlzgLOABcD1lGfVvK7bqiRpCDjS0JgjDWMuT+NLgV2Bc4HtgcuiJHttt1VJkkaRIw2zRPW9Fe8FPsTyXRbvyNP40U4Lk6SuONLQmKFhlomSbD/ga5Qng7oCeFWexr/utipJ6oChoTF3T8wyeRqfBzwLuBDYDbgqSrLXdFuVJGkUONIwS0VJNpdyV0VCeSbJLwFvz9N48aqeJ0ljw5GGxgwNs1y1u+IrwBbATcBr8jS+otuqJGkADA2NGRo08W2ZZwAHAkuBDwAfz9N4aZd1SVKrDA2NOadBE9+W+TLgbcBjwIeBC6Mk27bTwiRJQ8WRBq0gSrLtgDOBPYE/AccAn/MU1JLGjiMNjTnSoBXkabwI2Bs4HpgHfBb4cZRkW3damCSpc440aKWiJNud8qiKHSlHHd4HfDpP42Vd1iVJfeFIQ2OONGil8jS+nPIU1B8E1gQ+BVwcJdmOnRYmSeqEIw2qJUqynYHTgT0oj7A4EfhQnsYPdlqYJE2XIw2NGRpUW5Rkc4CjKE8KtS5wJ/BO4CwnSkoaOYaGxgwNaixKsi2ATwAT35Z5HvDOPI2v7q4qSWrI0NCYoUHTFiXZC4BTgB2AgvLMku/P0/j2LuuSpFoMDY0ZGjQjUZKtCfwT5VkkNwEepZzv8PE8jf/QYWmStGqGhsYMDeqLKMnWA44F3gWsDTwAnAycmKfxvV3WJklTMjQ0ZmhQX1XzHY4D3kh5mOZi4DPACXka39NlbZK0AkNDY4YGtSJKsgXAeyh3XcwDHqGc83BSnsYLu6xNkgBDwzQYGtSqKMmeTLnb4khgfnX3j4CTgHM9u6SkzhgaGjM0aCCiJFsfeAPleR62qu6+nfI01V/M0/jXHZUmabYyNDRmaNBARUk2FzgIeCuwf89D51F+u+Z38zS+v4vaJM0yhobGDA3qTJRkTwVeDxwBLKjuXgL8ADgL+F6exg90U52ksWdoaMzQoM5Vp6feDzgMeAWwQfXQEuBnwDnAOXka/6aTAiWNJ0NDY4YGDZUoyeYBLwIOBQ5keYAAuJZyEuV5wAWOQkiaEUNDY4YGDa1q/sNewAGUAeIZPQ8vA66gDBA/BS7O09j/8JLqMzQ0ZmjQyKjmQOwHvLC63Lzn4ceAX1AGiEuAX3gaa0mrZGhozNCgkRQlWQCezvIQ8UJg40mrLQJ+DlxaXS70vBCSHmdoaMzQoLEQJdkawE7APsBzqmWbSastBi6jHJG4slpuzdPY/wTSbGRoaMzQoLEVJdkmLA8QzwX2ZPlZKSf8EbiK5SHiSmCRIxLSLGBoaMzQoFmjOrRzJ2A3YNdq2YXyWzl7PQxczYpBYmGexksGV62k1hkaGjM0aFargsR2wLNYHiR2BdabtOpSyjkSv6I89HPiMs/T+M8DK1hS/xgaGjM0SJNU8yOeyopBYhdgsylWfwhYSBkgFlIGixsow4S7OKRhZmhozNAg1RQl2caUuzd2AnbuuT55VALKs1neRBkgFvVc3uShoNKQMDQ0ZmiQZqA69HMBZYh4RrVsV11uspKn3Q/cMmm5tbq8w90d0oAYGhozNEgtiZJsQ5YHiIkw8TRga/5y8uWEJcAdwG1TLLcDt+VpvHglz5XUhKGhMUODNGDV6MTmlOeR2IYyRPReX9kIxYQ/MClIAL8F7gLurJYHPP+EtBqGhsYMDdKQiZJsbeApwJY9y4JJt1c2UjHhYZYHiDtZMVBMXP8dcL/hQrOWoaExQ4M0YqqRig1ZMVBs0bNsXl1uWGNzS4F7gLt7lntWcv1u4CFDhsaGoaExQ4M0pqIkewLwV0wdKLYANq2WTYA5NTf7GHAf5S6SycvE/Q9Wy+JqeXDSpcFDK6gOc54HrNVzudYUt1f1WNPbc9d99KE1rj3x0L0BdvqXb1yweK35y4CiZ1kKPEo512himXx78n2PVssj1VLr+qhMgDY0SLNc9YG9PiuGiE2nuL0Z5ejFBsCaM/yxvR+uvR+yk+/rXZYBf17F5aoe611nKlN9EK7sw3GQ6wKEnoWVXB/EY3OAuZSvfe9lk/vmMfUv8pm+n6Zl7SWPcP2nXgnA9u84m4fnPaGLMiY8xiqCRZ7Gz+uwtsfN7boASd2q/sK5r1puWN361e6RdSjDw1TLE4F1ey7XneK+iV8Y8ymDyBr97ElDb+Iv+EcpR6B6w+HkQLmk5mNNby/d7bfXrw1cD/DXd92406VbPfMRVgxNvUGndyRkVbcnlidUy1qTLld3fT6wEctD21AZypGGEMJCgKIoduy6ljbY32izv9E37j3a32gb5v5M95IkqRZDgyRJqsXQIEmSajE0SJKkWgwNkiSpFkODJEmqZSgPuZQkScPHkQZJklSLoUGSJNViaJAkSbUYGiRJUi2GBkmSVIuhQZIk1TKQ0BBCeEEIYWEI4eYQwhdCCHOmWOfVIYQbQwi3hBA+0nP/eiGEc0IIN4UQLg8hbL+65wxaG/2FEHYJIVxcbffaEMJRg+xpUu2tvH4962QhhJvb7mNlWnx/bhZC+G4I4YYQwqIQwgGD6mlS7W31d0y13WtCCOeGEDYbVE+Tap9Jfy8NIVwVQlgaQji86XYHoY3+QggLQgg/CSFcX237Y4PqZyptvYY965wSQljaZg+r0uJ7dH4I4cvV58sNIYQ3t95MURStLpTB5GZgh+r2WcDrJq3zJOA2YHPK7y+/BNi3euzDwEer638H/HR1zxnk0mJ/Twe2q66vB9wE7DIu/fU89++BrwA3D7q3tvsDzgVeXV2fC2w0Lv0B2wK3AGtXt1PgEyPY39OAnYAzgcObbHfE+9sc2L26Pg+4EHjZoPtrs8ee5z4f+DKwdNz6Az4HvLu6HoBN2+5nECMNewB3FkVxXXX7dOCQSev8LfCzoijuKopiKeULPLHOIcAXAIqi+F/g6SGEjVbznEFqpb+iKG4simJRdf8DwPXAgnZbmVJbrx8hhI2BtwGdjRLRUn8hhO2AzYqiOKt6bGlRFPe23MtU2nr9ArAmsHYIIVAG27ta7WRqM+qvKIqbi6K4FvjzNLY7CK30V617eXV9CfBLYMv22liltl5DQghrUQbaY9oqvoZW+gshPBE4CDihWq8oiuLu9tooDSI0PAW4vef2bfzlL79VrTP5sTuq++psdxDa6u9xIYRtgN2Bi/tQb1Nt9nci8H7gkX4VOw1t9fcM4O4QwtdCCL8MIZwZQtiwr5XX00p/RVHcCHy6euwuYEfgpP6VXdtM+5vJdgehrf4eV70vXw78aJo1zlSbPR4PnF4UxT0zqnBm2upva+B3wGdCCFeGEP47hLDVTItdnUGEhtCndfrxnDa01V/5xBDWB74DHF0UxX3T3c4MtNJfCOGlwLKiKM5rXlJftfX6zQX2AT5SFMWzgBz4xDS2M1NtvX4bAQdTDp0+GbgVOLbpdvrAz5eZfb7MA84GTiqK4obpbmeG2nqPPhN4NvDFxhX1V5ufMbsAZxdFsStwDnDGNLbTyCBCw+2smJi2pPxrpe46d0x67CnAb2tudxDa6o8QwjpABpxWFMU3+1hzE231tw+wfwghBy4CtgohXNO/smtr8/15XTWsCPB1YLc+1dxEW/3tB9xaDacuA74J7NXHuuuaaX8z2e4gtNUf1WS8rwJXFUXxyRnWORNt9bg3sAPw6+pzZk4IIQ8hrDezchtrq787gHuLovhxdXswnzFtT5oA5lD+FdI7CeSIKSaB3M6Kk0BeWD32EVaciHX+6p4zyKXF/taknEj3gUH3NIj+Jj0/oruJkG29fmsAvwIWVLePBv5rjPrbk3Jy13rV7U8B6aj117POl1hxouBqtzvK/VX3nU75V3gYdF+D6nHS411NhGzzNTwf2LW6/jLg4tb7GdA/2n7AdZSzrc+o/lEOAr7Qs85hlEcI3AJ8bNI/5v9Uj10J7Li653Twpuh7f5RHFSwDrupZXjku/U3afkRHoaHl9+fzq/uuAb4PbD5m/R0H3EAZjr4NrD+C/e1P+RfbQ8B91fW1VrbdcemP8q/wonrtJj5fjuqivzZfw0k/o5PQ0PJ7dAfg59VnzAXA9m334ldjS5KkWjwjpCRJqsXQIEmSajE0SJKkWgwNkiSpFkODJEmqxdAgSZJqMTRIkqRaDA2SJKkWQ4MkSarF0CBJkmoxNEiSpFoMDZIkqRZDgyRJqsXQIEmSajE0SJKkWgwNkiSpFkODJEmqxdAgSZJqMTRIkqRaDA2SJKkWQ4MkSarF0CBJkmoxNEiSpFoMDZIkqZb/B4gFfmIoxm9uAAAAAElFTkSuQmCC"></button><div class="modal fade" id="plot_IepxKWNEQBENgoqJC6JRSUXcUFYxLAIy" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=1001030F0AAAEAE&amp;denomIds=10.1.3&amp;selectedTab=summary" target="_blank">Penicillamine 125mg tablets : 50</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=1001030F0AAAFAF&amp;denomIds=10.1.3&amp;selectedTab=summary" target="_blank">Penicillamine 250mg tablets : 189</a></li></ul></td></tr></tbody></table>
        </div>
      </div>
    </section>

    <section aria-labelledby="lowerHeading">
      <div class="container">
        <h2 class="pb-3" id="lowerHeading">Prescribing where NHS Newcastle Gateshead CCG is lower than most</h2>
      </div>
      <div class="container px-lg-4 mb-4">
        <div class="table-responsive">
          <table border="1" class="dataframe table table table-sm table-bordered" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Standard Deviation">std</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr class="row_1">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0801050P0&amp;denomIds=8.1.5&amp;selectedTab=summary">Hydroxycarbamide</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_0_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>14</td>
      <td>Other antineoplastic drugs</td>
      <td>15</td>
      <td>0.93</td>
      <td>1.00</td>
      <td>0.01</td>
      <td>-7.87</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_R0dmdsZW6lg722qtTqUtI1VLK46IgC2L"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_R0dmdsZW6lg722qtTqUtI1VLK46IgC2L" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0801050P0AAAAAA&amp;denomIds=8.1.5&amp;selectedTab=summary" target="_blank">Hydroxycarbamide 500mg capsules : 13</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0801050P0AAAEAE&amp;denomIds=8.1.5&amp;selectedTab=summary" target="_blank">Hydroxycarbamide 500mg/5ml oral solution sugar free : 1</a></li></ul></td></tr><tr class="low_number row_2">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0604030Q0&amp;denomIds=6.4.3&amp;selectedTab=summary">Prasterone</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_1_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>0</td>
      <td>Anabolic steroids</td>
      <td>3</td>
      <td>0.00</td>
      <td>0.97</td>
      <td>0.15</td>
      <td>-6.48</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_Kql0Xqo0iTFdgmVCJARCEEhILMAIhY0k"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_Kql0Xqo0iTFdgmVCJARCEEhILMAIhY0k" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"></ul></td></tr><tr class="row_3">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0101021B0&amp;denomIds=1.1.2&amp;selectedTab=summary">Alginic acid compound preparations</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_2_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>16242</td>
      <td>Compound Alginates and proprietary indigestion preparations</td>
      <td>16485</td>
      <td>0.99</td>
      <td>1.00</td>
      <td>0.00</td>
      <td>-5.04</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_4YvKC7Njoo0azZZUm8ZODIZqTMVbLVjD"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_4YvKC7Njoo0azZZUm8ZODIZqTMVbLVjD" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0101021B0AAAHAH&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Alginate raft-forming oral suspension sugar free : 581</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0101021B0AAALAL&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Sodium algin 500mg/Potassium bicarb 100mg/5ml susp SF : 689</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0101021B0AAAPAP&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Sodium algin 500mg/Potassium bicarb 100mg chew tab SF : 604</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0101021B0BEACAH&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Original Aniseed Relief : 133</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0101021B0BEADAJ&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Infant oral powder sachets : 1272</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0101021B0BEAFAH&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Peppermint Liquid Relief : 81</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0101021B0BEAIAL&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Advance oral suspension aniseed (Reckitt Benckiser) : 893</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0101021B0BEAJAM&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Liquid 10ml sachets : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0101021B0BEAQAP&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Advance Mint chewable tablets (Reckitt Benckiser) : 315</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0101021B0BEARA0&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Double Action chewable tablets mint : 81</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0101021B0BEASA0&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Double Action Liquid peppermint : 74</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0101021B0BEAUAR&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Peppermint chewable tablets : 44</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0101021B0BEAVA0&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Double Action Liquid aniseed : 24</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0101021B0BEAWAR&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Strawberry chewable tablets : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0101021B0BEBEAL&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Advance oral susp peppermint (Reckitt Benckiser) : 1333</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0101021B0BEBFA0&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Double Action chewable tablets mixed berries : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0101021B0BIAAAH&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Peptac liquid aniseed : 3694</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0101021B0BIABAH&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Peptac liquid peppermint : 6405</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0101021B0BQAAAH&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Acidex oral suspension aniseed : 6</a></li></ul></td></tr><tr class="row_4">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0407010F0&amp;denomIds=4.7.1&amp;selectedTab=summary">Co-codamol (Codeine phosphate/paracetamol)</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_3_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>11185</td>
      <td>Non-opioid analgesics and compound preparations</td>
      <td>180445</td>
      <td>0.06</td>
      <td>0.46</td>
      <td>0.12</td>
      <td>-3.43</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_iM5BSsQNR0XEozIgCuiATuE4KDggow7"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_iM5BSsQNR0XEozIgCuiATuE4KDggow7" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAg0AAACWCAYAAABdJrs9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAXEQAAFxEByibzPwAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAUC0lEQVR4nO3deZQdZZ2H8edNCCEEJAYk7JbCjAiKKCKOgoIrUIgyiIrLjCgICiICg6XCiM5BSsQNR0XEozIgCuiATuE4KDggo+w7ogex2BQEZN+T1Pzxvk03TYdUlr517+3nc857bnf1JflR6e77ve8amqZBkiRpcaZ1XYAkSRoMhgZJktSKoUGSJLViaJAkSa0YGiRJUiuGBkmS1IqhQZIktWJokCRJrRgaJElSK4YGSZLUiqFBkiS1YmiQJEmtGBokSVIrhgZJktSKoUGSJLViaJAkSa0YGiRJUiuGBkmS1IqhQZIktWJokCRJrRgaJElSK4YGSZLUSm9CQwizCaFJbXZP/k5JkrRc2dMgSZJaWaHrAiRJi5cV1XTgWcBaqc1LbWVgJWDmmDYdeAh4cNzjHcAtwM3AX+oyf7y3/xcadKFpmh78LWE28ED6bBWa5sHJ/0slabBkRRWA9YCNgeelNvLxuizf3uGFwG3ATcDVwBXAlcCVdZnfsxz/Hg0RQ4MkdSQrqjWBLYGXpcctgTUmeGoD3Ep8kR9pt6f2APDomPYIMRCsPKbNTm1NYH1iMFkfWIfYKzHejcBFwK+As4Hr6jLvwYuF+p2hQZJ6JCuqdYDtgNekx+eMe8rjxHf71wK/B65Lj9fXZf7IJNQznRggNgNeNKZtBIQxT72NGCDOAaq6zG9d3rVoMBgaJGmSZEW1MvA6YHtiSNh43FOuBS4kvqu/iDg08GhPi5xAVlSrAC8n1rwdsSdkbI/Eb4EfAT+qy/xPva9QXTE0SNJylBXVusBOwJuA1xInKY64jtjdfzbwv3WZ39n7CpdcVlSrAlsDrwd2AbIxX74MOBU4wR6I4WdokKRllBVVBrwttS3GfOk+4L+B/wJ+WZf5n3tf3fKVJmu+BNg1tb9PX1oInAkcD5zpyozhZGiQpKWQFdV6wG7A24GtxnzpBuCnqZ1Xl/ljHZTXEylAbAq8B3gvcaIlxAma3wWOq8v8hk6K06QwNEhSS2msf1fiC+S2Y750A/DD1K6ciisNsqKaQRyW2ZM4h2Masffhx8DRdZlf0GF5Wk4MDZL0NLKimgZsQwwKuxGXLkLcIGkkKFwyFYPCoqRemPcD+xI3pAI4H/gC8JO6zBd0VZuWjaFBkiaQFdU8YA9gL+C56fLDwGnErvdf1WW+sJvqBkNWVLOAdwMHMrpy5HrgCODEusznd1Wblo6hQZKSNEb/amAf4B+BGelLvwa+A5xWl/l9HZU3sFJvzY7AwcT7CzE8fAY42fAwOAwNkqa8rKieQRx++CCj74jvZnQy33XdVDZ8sqJ6JXA4cf8KgD8Qw8MPHLbof4YGSVNWVlQbAh8G3gesmi7/FvgGcGpd5g93Vduwy4pqG+DTxM2jIG50dQhxuabzQ/qUoUHSlJKGILYFPgLsTNwu+VHgJOCrdZlf3l11U09WVK8G/o042RTiVtUH12V+aXdVaVEMDZKmhKyoViAulzyEuDkRxDMVvgZ8sy7zO7qqbapLQW4n4ChGh4dOBD5Zl/lNnRWmpzA0SBpqaQb/HsBBjK6CuAz4InDKMG++NGhSsHs/cdhiHrEH6GjgyLrMfd3oA4YGSUMpK6o5xH0CPsLoXgG/AD5H3NLZcfM+lc66OBj4F2AWcEv6/BT/3bplaJA0VLKimgscAOwPrEbclfBU4CjHyQdLVlQbAJ8nnukB8Xju/esyv6qzoqY4Q4OkoZAV1ZrETYT2BVYBHicumfxcXeZ/7LA0LaOsqLYDjgFeACwgzkM5zD0zes/QIGmgZUW1BvAxYliYRRwHP57Ys+AkuiGR5jt8iLinw2rAn4nLZf/TIYveMTRIGkhpQ6YDU1uVuMXzscTDkQb+CGpNLPUofRF4V7r0U2A/A2JvGBokDZSsqFYm9ioUwFziMMSxwGfrMr+ty9rUO1lRvZ64CdeGwIPAYcR9NtySehIZGiQNhKyoViQuxzsMWJs4wfG7wGfqMr+xw9LUkbSc9lDi3hsrAJcCH6jL/JJOCxtihgZJfS0rqunErujDgeeky6cAn/JMCAFkRbUpcBzwCmKYPAb417rM7++0sCFkaJDUl9IugbsQtxjeJF2uiLPmL+usMPWldJLmnsRdJVcj7u2wX13mZ3Ra2JAxNEjqO1lRbU2c7LZlunQu8Im6zM/vrioNgqyo1gK+BLwjXTqdGB5u7a6q4WFokNQ3sqJ6DnHHxt3SpUuATwBnuaxOSyIrqu2BrxOHtO4jLss9ri7zhZ0WNuAMDZI6lxXVasRwcACwIrFr+ePA9/0lr6WVVtocTjx3ZBrwa2Av58IsPUODpM6kDXv2JG7Y8yzgIWJPw9F1mT/UZW0aHllRbUHc8Gtz4DHiPJmjPKxsyRkaJHUiK6o3EOctbAo0wPeAQx171mTIimoG8FHiCZorAVcDe9ZlfkGnhQ0YQ4OknsqK6vnAF4Ad0qVzgY96mJR6ISuqjYjLM7cjhtWvAp+sy/yBp/0PBRgaJPVIOiPicGAfYDrwR+LRx6c7yVG9lJbz7kEMr3OAm4B96jL/WaeFDQBDg6RJlXZy3A/4V+L6+XuJY8r/Xpf5o13WpqktLc/8CqNHb38fOKAu8zu6q6q/GRokTYr0bu4twOeJ5wMsIJ4R8Wl/KaufZEW1M3F55rrAXcS5DyfaA/ZUhgZJy11WVC8mbrDz6nTpZ8DBdZlf211V0qKlU1OPJB6/DXAWsHdd5n/qrqr+Y2iQtNxkRbUOcATwz0AArgEOqsv8550WJrWUFdUrgW8BzycuAT4MOMbTMyNDg6RlljbROYi4695s4E7iL9vj/WWrQZMV1Uzi5mKfAGYQdyb9YF3mF3VaWB8wNEhaaumQoHcSu3XXI26c8xXgiLrM7+2yNmlZpdMzvwX8A3F55nHEM1D+1mlhHTI0SFoqqRv3S4weKnUa8LG6zG/oripp+UrBeA/iTqWrEydKfgz4zlTc4tzQIGmJTHCo1MXAgXWZn9ddVdLkyopqdeCzwF7E+Tq/AT5Ul/nlnRbWY4YGSa2k2eUjh0rNBG4ljvueNBXfcWlqyorqZcA3gJcAC4GvAYdNleE4Q4Okp5U2Z/oAcXOmkUOljiIeKuXPsqacrKimA3sTVwrNAW4n7m469Hs7GBokTShtzrQrcZLjRsSJYCcQ9+n3UClNeVlRrUkcqntvunQusG9d5ld3VtQkMzRIeoqsqLYh7uS4Vbr0c+Ikxyu6q0rqT1lRbU0cptiM0Z1PD6/L/M5OC5sEhgZJT0gnUB4JvDldugw4pC7zX3RXldT/sqJagXjGyuGMnrHyGeIZK491WNpyZWiQRFZUaxN/2e0JTANuBD4JnOwkR6m9CU5zvR44hCE5zdXQIE1hWVGtChyc2srA3cTJXV+ry/yRLmuTBllWVJsQh/h2TJfOIw7x/aa7qpadoUGagrKimgV8ECiIKyIeBY4BjqzL/O4ua5OGSVZUbwC+ALwgXTqDuKvkQB7eZmiQppC0p/5exP0W1iauiDiRuM78xi5rk4ZVWqL5buIchw2I+zt8D/hUXeY3d1nbkjI0SFNAVlQziFvhHgqsny6fSpzhPZDveKRBkxXVSsQevkOBucQevm8CZV3mf+mytrYMDdIQS8MQ7yNOxNogXT6D+A7H5ZNSB7KiWo04j+ijxFNhHyEu0/xcXea3dVnb4hgapCGUJjjuQzyuel66XBF7Fi7urDBJT8iK6lnEnST3JU5Efpi4RfVRdZnf3mVti2JokIZI+iW0L7A/8EzinIXTgM9OtYN1pEGRdpYcCQ+ziD0P3yZu1V53WNpTGBqkIZCWdx0AvAdYibgr3YnEsdLruqxNUjtZUc0jDiXuTRy2WACcTBy26IutqQ0N0oBKZ0O8jjguukO6/ADxHcqX++0diqR20jHc+xF7DOemyz8FjgbO63KTKEODNGCyoppD7FHYB9gkXb6ZuM/C8XWZ39NVbZKWn6yoZhOXSB8ErJcuXwp8GfhhF9tTGxqkAZEV1UuJQWF34qQpgAuBLwI/rsv88a5qkzR50vH0uxOHIDdPl28Dvg4cW5f5Hb2qxdAg9bHUTfl24rLJLdLlB4GTgG/WZX5pV7VJ6q00JPkqYnh4MxCIez2cSlyy+X+TPXRhaJD6THpXsSPwT8BOwIz0pauJy7FOqsv83o7Kk9QHsqLaEPgwcdO2Z6TLVxPDw4mT9TvC0CD1gXSs7jbAbsDbgNXTl/4G/AA4AbhwGE7Jk7T8pHkP7yAOXb40XX6wLvNVJuPvMzRIHUlbO28HvBXYBVgjfelx4kZMJwBn1mX+aDcVShokad7T3sA76zKfPRl/h6FB6qE0R+GNxOGHHYkbMAHMB35B3Ijp9LrM7+qmQkmDLiuq1RyekAZQOt1uc2B7Ykh4OTAtffkx4H+IQeEnHkktqd+t0HUB0jDJimoa8ELisMN2xJnOc8Y85VbgzNR+WZf5/T0vUpKWkqFBWgbpYKgtiT0ILwdeyegObhCXQ50DnEWcp3CVkxklDSpDg9RSVlSrAJsBLwJeAmwFvIC4VnrEY8C5xKBwDnBBXeaP9LhUSZoUhgZpnKyoZgJ/Bzwf2Jg43LA5sBFPDggQt2/+7Zh2WV3mD/euWknqHUODpqSsqGYBGfDcMW0jYkh4LqOTFceqgctTuwK4qC7zW3tQriT1hSkVGtIktdnAKsTjg2emx4nazDGP01ILYx7DIq4tIC6fm09cbz9/XBt77VHg4dQeGfPxE5/XZT5/cu7GcEqrFeYC84A1gbWJB72Mb2s9zR9zC/A74Lr0eC1whQdBSZrqBmrJZdp3+xnETXDGt2emr62aHif6eFWe2r3c7+bzNKFiCVur/6Yu84W9+V8blf5tZ/LkIDcLWC21OWMe5yzi2prE74WJegnGmg/cBNwwQfuDKxokaWKdhYb0IjGbiQPA2Lb6uM+XpndkIXBfavenWh4mvtN/ZFwbf+0xYu9Bk/6cZtzHYx8hvmDNSHWObeOvzSC+QM5KbaUxHy/q2syl+H9fGo8R78OiekjGX1vIaE/L4tp0ntyLMxIQVlwOdT8O3A78NT2OtFvGtb92EYwkadBNamjIimo/YI05D9+/1uXH7L43wKYHnHLVgzNXnksMAEvyIvg4cOcE7a70eDdwL6PBYGxIeGgYlrml4ZWxQePpAsfStLF/zoo8NfAsb2ND2vjHkXZvavekNtHHI4/3DcO/syT1q8me0/BVgEenz3jiwsIw7YXEd+4jL/aLCgHj2/1T/QUhvTseGUboqdQzNI2Je06mM9oDs7i2gBgMHpvq/56SNGgmOzQcAty5xkP33E8875tdrjlnve+/eIe/2D08WNIL/AJGX/QlSVPMQE2ElCRJ3VncLHNJkiTA0CBJklrqzfBEx0II1wA0TbNp17UMKu/hsvH+LTvv4bLx/i0776E9DZIkqSVDgyRJasXQIEmSWjE0SJKkVgwNkiSpFUODJElqZUosuZQkScvOngZJktSKoUGSJLViaJAkSa0YGiRJUiuGBkmS1IqhQZIktTJUoSGEsG0I4ZoQwvUhhONDCNMneM4pIYQ7QgjXd1Fjv1vcPQwhbB5COD895+oQwv5d1dqPWty/2SGEC0MIl6fnHRdCWKGrevtRm5/jMc+t/Fl+spa/B5v0PTjSVu+i1n7V8h7OCyGcEUK4LoTw+xDCTl3U2mtDExpCCNOA44HdmqbZCHgG8O4Jnnos8MZe1jYoWt7Dh4D3paNhXwF8OISweW8r7U8t79/DwGuaptkceCGwxgTPmbKW4OeYEMK7gL/1sLy+twT3b0HTNJuPaXf1tNA+tgT38HvASU3TbAxsCvymd1V2Z2hCA7Al8Oemaa5Nn38b2HX8k5qmORt/0SzKYu9h0zR/aJrm9+nj+4DfAev3tMr+1eb+LWya5oH06QrATMAd1ka1+jkOIawB7Asc0cPaBkGr+6entdh7GEJ4HjCvaZpTAJqmmT9VgtcwhYb1gJvHfH4TvpgtqSW6hyGEDYGXAudPcl2DovX9CyFcANwB3AecNPmlDYy29/DLwKHAI70oaoC0vX/TQggXhRAuCSEc2JvSBkabe7gx8NcQwskhhMtCCCeEEOb2rMIODVNoCF0XMARa38MQwhzgdOAjTdPYcxO1vn9N02wFrAvMBbadrIIG0GLvYQhhB2L3+tk9qGfQtP0efHbTNFsCbwB2CSHsPok1DZo293AF4FXAEU3TvBiogc9PZlH9YphCw808OQ1uANzSUS2DqtU9DCGsDFTAt5qmObVHtQ2CJfoeTMMUPwHeNMl1DZI29/BVwGtDCDXwa+DZIYQre1Ne32v1Pdg0zc3p8S5iT9crelLdYGhzD28Grm2a5ur0+Q+ALXpQW+eGKTRcDKwXQtgkff5+4Mcd1jOIFnsPQwgz0rWzmqY5psf19bs292/N1EtDCGEmsCNwTU+r7G+LvYdN03y8aZr1mqbJgK2BG5um2ay3ZfatNt+DzwwhrJQ+XgnYGTB0jWrzWnIxsGIIYSRcvJ4p8nM8NKGhaZoFwJ7AaSGEPwIPAP8RQtg5hHD8yPNCCBVxlmsWQrglhPDxbiruPy3v4duIPyBvGbNc660dldxXWt6/dYBz0jvjS4FriTO1RfufY02s5f3bGLgohHAFcAlwFXGyn2h3D5umWQh8CDgj/SxvDxzcVc295NHYkiSplaHpaZAkSZPL0CBJkloxNEiSpFYMDZIkqRVDgyRJasXQIEmSWjE0SJKkVgwNkiSpFUODJElqxdAgSZJaMTRIkqRWDA2SJKkVQ4MkSWrF0CBJkloxNEiSpFYMDZIkqRVDgyRJasXQIEmSWjE0SJKkVgwNkiSpFUODJElqxdAgSZJaMTRIkqRWDA2SJKmV/weyjOkQUIsc5AAAAABJRU5ErkJggg=="></div></div></div></div></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0407010F0AAAAAA&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 8mg/500mg tablets : 7338</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0407010F0AAABAB&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 8mg/500mg capsules : 319</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0407010F0AAACAC&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 8mg/500mg effervescent tablets : 655</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0407010F0AAADAD&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 30mg/500mg capsules : 563</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0407010F0AAAFAF&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 30mg/500mg effervescent tablets : 250</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0407010F0AAAHAH&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 30mg/500mg tablets : 926</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0407010F0AAAKAK&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 15mg/500mg tablets : 867</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0407010F0AAAPAP&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 12.8mg/500mg tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0407010F0AAAVAV&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 15mg/500mg capsules : 120</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0407010F0AAAWAW&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 15mg/500mg effervescent tablets sugar free : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0407010F0AABABA&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 8mg/500mg effervescent tablets sugar free : 22</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0407010F0BEAAAD&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Tylex 30mg/500mg capsules : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0407010F0BGAAAF&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Solpadol 30mg/500mg effervescent tablets : 51</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0407010F0BGABAH&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Solpadol 30mg/500mg caplets : 30</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0407010F0BGACAD&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Solpadol 30mg/500mg capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0407010F0BHAAAH&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Kapake 30mg/500mg tablets : 11</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0407010F0BSAAAH&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Zapain 30mg/500mg tablets : 11</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0407010F0BXAAAA&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Migraleve Yellow tablets : 12</a></li></ul></td></tr><tr class="row_5">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0&amp;denomIds=1.5.1&amp;selectedTab=summary">Mesalazine (Systemic)</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_4_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>4507</td>
      <td>Aminosalicylates</td>
      <td>11657</td>
      <td>0.39</td>
      <td>0.62</td>
      <td>0.07</td>
      <td>-3.35</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_ZpzCqBhvKU1UnBgTRg2JEkGeCV5Lo0lI"><img width="250" class="h-auto" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAg0AAACWCAYAAABdJrs9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAXEQAAFxEByibzPwAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAV+UlEQVR4nO3de7glVX2n8Xc1zU0aQS7KVUvlEiGgjDYERPRRJ4kW3hN1HhhkhMyEQU0yZpzCqBhvKU1UnBgTRg2JEkGeCV5Lo0lIzGO8hEs3NI1CEMpuJhLbRm6J3U131/yx1uHsPhxOVfc++9Te57yf56ln71279uG3qNP7fPfaq9YKTdMgSZLUZlnfBUiSpMlgaJAkSZ0YGiRJUieGBkmS1ImhQZIkdWJokCRJnRgaJElSJ4YGSZLUiaFBkiR1YmiQJEmdGBokSVInhgZJktSJoUGSJHViaJAkSZ0YGiRJUieGBkmS1ImhQZIkdWJokCRJnRgaJElSJ4YGSZLUiaFBkiR1YmiQJEmdGBrahLAPITRp26fvciRJ6ouhQZIkdbK87wIkaVJlRbUMeAJwJPBE4HBgBfCYtO0N7AlsBv49bT8DHgDuAtYD64ANdZlvX+j6pZ0Vmqbpu4bxFr+SeDA9WkHT/Fuf5UjqR1ZUhwInDWxPB54E7D4PP34LUAOrgRuAVcCqusw3zMPPluaNoaGNoUFakrKiOgx4YdpeABw2y2H/ynRvwXpi78F9xN6EqZ6FLcTehr2Z7oHYDziC6R6KI4HHz/Lza+Cvga8B19Rl/tN5aZy0iwwNbQwN0pKQFVUAVgKvAX4ZOG7g6W3AzaQegLTdWJf5/fP4398feAbwHwa2pw0csh34LvAV4DN1md8xX/9tqStDQxtDg7RopaBwIjEovBZ48sDTtwJ/Q/yk//d1md/XQ30HE3s6fjFtg70d3wYuB66qy/wnC12bliZDQxtDg7ToZEW1L3A2cAFwwsBT3wY+C3yuLvN1fdT2aFLAOR74VWLtT0lPbQW+DFwC/ENd5r6pa2QMDW0MDdKikRXV8cSgcA6wb9q9GriC+Im97qm0nZICxCnAWcQekoPSU6uI4eGzdZlv7qk8LWKGhjaGBmmipT+wzwV+h9jVD7AJuBL4WF3m1/ZV23zIimoP4tcrv0W8qgPgbmJ4+Ghd5r5nad4YGtoYGqSJlMLCi4hh4bS0+07gY8BldZlv7Ku2UUjtfQ7wm8DLgUC8uuN9wKX2PGg+GBraGBqkiZL+eL4EeCfTn7zXEv94XlWX+daeSlswWVEdQ2z/a4nhYT3wLuDPlkL7NTqGhjaGBmliZEV1GvB+4PS063rgvcAXluKMi1lRnQC8G3hZ2rUWuLAu82/0V5UmmaGhjaFBGntZUf0csSfhFWnXzcBFQOXVBJAV1SnEMPXctOsK4LfrMv+X/qrSJDI0tDE0SGMrK6oDiN3uvw7sRuyGfztweV3m2/qsbdykr21eA3yQON/Dg8DvAh+py/yhPmvT5DA0tDE0SGMnK6rdgPOJXz0cCNyb7n+0LvNNfdY27tIcFW8nXm2xnHjJ6bl1md/Ya2GaCIaGNoYGaaykcQt/SJxmuQE+AfyOizvtnKyongb8CXAGcYKodwO/Z6+D5mJoaGNokMZCVlQHAh8AXp92fQd4Y13m1/VX1WRLS3u/ASiJC2qtIvY63NRrYRpbhoY2hgapV+m7+LOADxNnPtwAvAX41FK8ImIUsqI6CvhT4jwPDwFvA/7A/7+aydDQxtAg9SYrqqOBPyYuTQ3wcaCoy/ye/qpanFKvwxuJvQ57ERfqOqcu87t7LUxjxdDQxtAgLbisqJYDbyaO7t8TuAX4b3WZf7PXwpaAtD7HZ4mLY20gBoe/6rcqjQtDQxtDg7Sg0oRElwHPBDYD7wE+UJf5ll4LW0KyotqbeGnmBWnXB4G3eg5kaGhjaJAWRFp46a1p2x34FnBeXebf77WwJSwrqlcCnwT2Jy4b/uq6zO/qtyr1aVnfBUhSVlTPAq4DLiYOxPsN4AwDQ7/qMr8aeDrwXeBU4IasqJ7fb1Xqkz0NbexpkEYmdYO/E/ht4oeYvwPOr8v8jj7r0o5SL9CHgAuB7cSVQz/g1RVLj6GhjaFBGomsqJ5NvMzvGOABYnD4uGtFjK+sqM4iXsGyN/BF4iDJ+/qtSgvJ0NDG0CDNq6yoVhCnfH4jcdnmrwC/Xpf5+l4LUydpoOpfAkcDtwEvr8v8e/1WpYXimAZJCyYrqhcAa4A3EdeLOAc408AwOeoyXwOsBL5E7CX6blZUL5v7VVos7GloY0+DNLSsqPYD/oC4yBTET6pvcOKgyZUmg3oHcfAqxDk13uU4h8XN0NDG0CANJSuqHLgUOBz4MXBhXeb/t9+qNF9SL8OngX1xnMOiZ2hoY2iQdklWVIcAlwCvSbsuB36zLvON/VWlUUgrZn6e+HXFrcRxDl4uuwgZGtoYGqSdkrqtzyOuSLk/sB64oC7zqtfCNFLpK6jLgTOJV8OcXZf5F/utSvPN0NDG0CB1lj5xXkpcLXE78BHgHXWZPzjnC7UopMB4MXGsA8Q5ON7tOIfFw9DQxtAgtcqKak/gorTtAawGfq0u8+t6LUy9yIrq5cRxDiuI4xz+c13m9/dbleaDl1xKGkpWVGcQQ8LFwDbgfwIrDQxLV13mnwdOJs7j8FLiZZnH9luV5oM9DW3saZBmlRXV44D3A7+Wdn2NOHbhzv6q0jhJ4xz+AsiB+4njHL7Ub1UahqGhjaFB2kH63vpcoAQOBjYQF5i60imgNVP6fXkn8Pa062LgPY5zmEyGhjaGBulhWVGtBD5K7HqGuGzyW+oyv6e/qjQJsqJ6BfAp4jiHzwOvc5zD5DE0tDE0SGRFdTBxvYjzietFXEuc0fGfei1MEyUrquOIgeFo4PvE+Rxu7bcq7QxDQxtDg5awdFXEm4C3AY8FfgIUwGV2L2tXZEW1P3Gcw4uJ4xzOqsv8y/1Wpa4MDW0MDVqCsqIKwK8QBzo+mXhVxMeAi+sy/2mftWnypXEOv0sMow1xnMN7DaLjz9DQxtCgJSYrqlOJi0udlnZ9iThuwWmBNa+yonol8OdMj3M4py7zB/qtSnMxNLQxNGiJyIrqBOK4hZekXTcCb67L/G/7q0qLXVZUxxMDw1HA94jjHG7rtyo9GkNDG0ODFrmsqJ5C7Co+izjIcR2xu/jTdZlv67M2LQ1pnMNngBcB9xHHObhWyRgyNLQxNGiRyooqI077/F+A3YnzLbwHuLQu8809lqYlKCuq3YB3AW8ljnN4B/A+xzmMF0NDG0ODFpmsqJ5KfGM+B1hOHMH++8AlLiylvmVF9SriOId9gC8Dr6/LfEO/VWmKoaGNoUGLRFqB8n8BZwO7AfcCHwb+d13m9/ZZmzQojXO4GjgGuJs4EdTX+61KYGhoZ2jQBEuXTp4OvAU4M+2+B/gg8FFn5NO4yopqBTHUnp92XQJcVJf5pv6qkqGhjaFBEygrquXAy4grTp6Sdv8/4hvvpV7WpkmRLsv8OHAAcBNx0as1/Va1dBka2hgaNEHSdM/nAxcAR6bdNxPHLFxZl/mWvmqTdlVWVIcT1614PvAQ8D7iIEl/nxeYoaGNoUFjLn0FsRK4EHgtsEd66uvE7t2vufqkJl2aRfJNxLlEHgOsAc6ry/zaXgtbYgwNbQwNGlNZUR1EHNT4euCEtPt+4DLgY06Qo8UozSvycWKvw3bi+Jx31mX+770WtkQYGtoYGjRGsqLaHXghMSi8jDi/AsTZGy8FLne8gha71Lt2PnG688cSJyR7M/CX9qqNlqGhjaFBPUvdss8hfvXwK8BB6al7iasFfrIu81U9lSf1JiuqI4iDe1+Vdl0D/EZd5jf3V9XiZmhoY2hQD1KPwunE3oRfBQ5LT20FvkYMC5/z8jMJsqJ6IfAR4Djiiqx/BLyrLvONvRa2CBka2hgatECyotoP+CXgpcCLgcelpxrg74Argat9I5QeKQXt/05cR2U/4AHgQ8CHnI9k/hga2hgaNCJZUe0B/AJxjMILgZOJMzUCbAb+FvgC8KW6zH/US5HShMmK6vHEdSv+K3HMzz3A+4mTmTlYckiGhjaGBs2TrKgeS5xo6TTg2Wl7zMAhPyJeJvlF4OuuAyHturQg2zuA1wHLgH8lfoXxJ3WZ/7TH0iaaoaGNoUG7ICuqfYATgZPStpJ4WeSygcMeBP4e+Bvgr4HvOfJbml9ZUR1L/Mri1cSl3/8N+CRxgbY7+6xtEhka2hgaNIesqB5DXFTnaQPbz6d9y2Ycvh74FvCP6fbGusy3Lly10tKVFdUxwG8B5wJ7Eed4uJp4qfI1LsHdjaGhjaFhyUrXgh8IPDFtTxq4P7Ud8igvXwesGthuqMv8rlHXLGluaar1C4A3AAen3TWx9+HP/Hc6N0NDG0PDopUGIh7JI4PAYDjYe44fsZXYe3ArcAvwvamtLvN7Rle5pGFlRbU3cX6H84Dnpd3bieOKrgI+79iHRzI0tDE0TKysqPYHnszcvQRhjh/xU2KPwTrghwP3p7a76zLfNqr6JS2MrKiOJs6yei7TvYdbieONrgK+4AeByNDQxtAw1lIwOAo4emCbenzgHC/dCtzFjiFgMBisdzpmaWlJS8o/jzho8pVMv4dsB74DfDVtq5bqGAhDQxtDw1jIimpf4tUIz0jb8cRgcNCjvGQz8APgDh7ZS/BD7CWQNIcZAeJM4NCBp39M7IX4RtpuWypXPhka2hgaFlQafHgY0+FgajtqlsO3EIPB7cA/z9juWqqfBCTNr/S+dCLworQ9m+mJ2ADuBv6BeFXUtcDqxTqRlKGhjaFhpFIPwsnAqWk7mdl7D+4EVg9sa4B19hZIWmhpyvfTgTOA5wLPYscQsQ1YSwwQ16XbNXWZb1ngUuedoaGNoWHepLR+NNMB4VTinAaD8xlsAW4mBoMb0+1NdZnfu7DVSlI3WVGtIM70ejIxQKxkepG5KVuI72nXAjcRP/isrcv8vgUsdWiGhjaGhl2WLml6FjGRn0YMCTMHJ94FfHtgW1WX+eaFrFOS5ltWVIcxHSCmtgNmOXQd8YPSmoHb74/r+6ChoY2hobM0acrUmgqnA88kLhgzZQtwAwMhwYlUJC0Fqac1IwaJE4i9rCcAT+WRl35vA27jkWHizr6/kjU0tDE0zCr9AziW6ZDwbOLUyYM2At8kTpv8j8D145qeJakPaSr645gOEVO3h85y+M/YcTK5qdvb6zJ/aCHqNTS0MTQAD39ndxJxKeeprxtmDli8jRgOpoLCkrkMSZLmU1ZUBxIvLR8MEj8P7DfL4VuJV409HCbqMr9iFHUZGtoswdCQrmg4ifj1wtR2LDt2oT0EXM90QPhWXeY/XuBSJWnJSD28hxAXxjtuxu0TBo+ty3yu2W532fJR/FBNhvQLeCjxF+7pTAeEY3jkd2zriCHhWmJQuK4u858tXLWStLSlntsfpe2aweeyojqAHUPESNjT0GYR9DSka4qfmranML2U83HM3tVVEwcsXp+2G+oy37AgxUqSxpY9DRMq9RLsQ1zadWp7PHA4cMTA7ROZ/TIfiINqbiB+D7aW6YCwcaTFS5Im0pLuaciKahkxOC0nzuY1eLsc2O2UdWv2/ewVF60BOPN1l/zCzYcctYU4GdGydOyyIR/vAew1sO09y/29gccSewWmtv2BPTs0cxNx/YU7mF6L4XZiUFjnVMuSpK5672nIiup44h+/PWbc7kn8gznb/bbHXY7t1PabDjn64fs/OOCI7wzR1Pn0EHAfcWrlDTO2u2Zs93gFgyRpPvQeGoiTViyErcSVDzcDDxD/8G4lTqIx2+1WYNtuzbbtxJXOWL5921eJExRtIy6Vun3G/V15vIXYG7CJ+HXBbPc3AfcTg8J9wCaDgCRpofX+9URWVF9h+o/5lhm3mwaeG+b+5l2eRWsRDISUJGk+9B4aAEIIawGapjm+71rmk+2aLLZrstiuybEY2wSLt11zWdZ+iCRJkqFBkiR1ZGiQJEmdGBokSVInhgZJktSJoUGSJHUyFpdcSpKk8WdPgyRJ6sTQIEmSOjE0SJKkTgwNkiSpE0ODJEnqxNAgSZI6GXloCCE8L4SwNoRwewjhEyGE3WY8v08I4Z9CCKvTcf8nhLA8PXduCGFjem51COGPRl1vV23tmnFsFUK4feDx8hDCZem1a0MIz1mYqtsN2a6JPl8hhGag9tUhhAPT/ok+X3O0a9LP1xNCCF8IIXw/hHBrCOHMtH/Sz9ejtWtiz1cI4RkzfgfvCSF8OD03ludryDaN7bkaWtM0I9uIoeR24Lj0+CrgdbMcs2Lg/tXAuenxucAnRlnjqNo1cOxZwKeB2wf2nQ98Jt0/EbiNNGfGhLdros8XsPVRXj/R52uOdk36+for4NXp/nLgwEVyvh6tXRN9vma85p+B08b1fM1Dm8byXM3HNuqehpXAvzRNc0t6/EngVYMHNE2zvWmaB9PD5cCewLjPONXaLoAQwkHAhcB7Zzz1KuATAE3T3ARsBE4aWbXdDduucdWpXXOY6PM1gVrbFUI4FnhC0zRXATRNs7Vpmo3p6Yk9Xy3tGlc79XsYQjiFGAq+lXaN4/katk2L1qhDwxHA+oHH64AjZzswhPBdYANwP/AXA0+9JIRwYwjh6yGElSOrdOd0bdclwNuATbv4+oU2bLtgss/XshDCtSGE60MI/2MXXr/Qhm0XTO75+jngxyGEK0IIq0IInwohHLATr+/DsO2CyT1fg84GLh/i9Qth2DbBeJ6roY06NISuBzZNcwpwOHAA8Ly0+8tA1jTN04mfaj8XQlgx30XugtZ2hRBeBGxrmuaaXXl9T4Zt18Ser+RJTdOsBH4ReEUI4T/t5OsX2rDtmuTztRw4A3hv0zQnATXw+zvx+j4M265JPl/xwDhe7dXs+Ad2HM/XsG0a13M1tFGHhvXsmM6eCNz1aAenrym+CLwkPf5J0zQ/S/e/kV577Miq7a5Lu84AXhBCqIFvAk8KIdy0E6/vw1DtmvDzRdM069PtRmJv12k78/oeDNWuCT9f64Fbmqa5OT2+EnjmTry+D0O1a8LP15RfAu5omub2gX3jeL6GatMYn6uhjTo0XAccEUI4Lj0+jzjQ8WEhhMeHEPZP9/cEXgysTY8PGzjueCAD7hhxzV20tqtpmouapjmiaZoMOB34YdM0J6anryYO/iGEcCJwMHDDQhTeYqh2TfL5CiE8LoSwV7q/F/BSYCrkTez5mqtdk3y+0jF7hBCm3tj/I+l9gwk+X8zRrgk/X1POJg6gHjSO52uoNo3xuRreqEdaAs8HbgF+APwpsfvtpaSRpcAzgFXEN7K1xK64Zem596V9q4FrgV/ue+Ro13bNODZjx6sMdgf+nDg69xbguX23Z57aNbHnCzgVWAPcmNrw/oHfw4k9Xy3tmtjzlY55DvGPy03AV4FDJ/18tbRr0s/XCuBe0tUgA/vH8nwN2aaxPVfDbi6NLUmSOnFGSEmS1ImhQZIkdWJokCRJnRgaJElSJ4YGSZLUiaFBkiR1YmiQJEmdGBokSVInhgZJktSJoUGSJHViaJAkSZ0YGiRJUieGBkmS1ImhQZIkdWJokCRJnRgaJElSJ4YGSZLUiaFBkiR1YmiQJEmdGBokSVInhgZJktSJoUGSJHViaJAkSZ0YGiRJUif/H+/PqCiWJhsGAAAAAElFTkSuQmCC"></button><div class="modal fade" id="plot_ZpzCqBhvKU1UnBgTRg2JEkGeCV5Lo0lI" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0AAAAAA&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 400mg gastro-resistant tablets : 38</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0AAABAB&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 500mg suppositories : 48</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0AAACAC&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 1g/100ml enema : 10</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0AAAIAI&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 500mg modified-release tablets : 12</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0AAAJAJ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 1g suppositories : 209</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0AAAKAK&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 1g/application foam enema : 24</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0AAALAL&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 2g/59ml enema : 49</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0AAARAR&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 1.2g gastro-resistant modified-release tablets : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0AAASAS&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 800mg gastro-resistant tablets : 24</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0AAAXAX&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 1g gast res MR gran sachets sugar free : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0AAAYAY&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 1g modified-release tablets : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0AAAZAZ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 3g gast res MR gran sachets sugar free : 10</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0AABCBC&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 1g gastro-resistant tablets : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0BBAAAA&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Asacol 400mg MR gastro-resistant tablets : 221</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0BBAFAS&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Asacol 800mg MR gastro-resistant tablets : 185</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0BCACAI&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 500mg modified-release tablets : 298</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0BCADAJ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 1g suppositories : 65</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0BCAEAN&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 1g modified-release granules sachets : 108</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0BCAFAT&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 2g modified-release granules sachets : 133</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0BCAGAY&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 1g modified-release tablets : 46</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0BCAHBA&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 4g modified-release granules sachets : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0BDAAAH&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 250mg gastro-resistant tablets : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0BDACAB&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 500mg suppositories : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0BDADAL&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 2g/59ml enema : 33</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0BDAEAK&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 1g/application foam enema : 20</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0BDAFAX&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 1g gastro-resistant modified-release gran sachets : 64</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0BDAGAP&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 500mg gast res MR gran sachets : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0BDAHAU&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 1.5g gastro-resistant modified-release gran sachets : 90</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0BDAIAJ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 1g suppositories : 20</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0BDAJAW&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 500mg gastro-resistant tablets : 13</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0BDAKAZ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 3g gastro-resistant modified-release gran sachets : 56</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0BHAAAR&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mezavant XL 1200mg tablets : 275</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0BIAAAS&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Octasa 800mg MR gastro-resistant tablets : 698</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0BIABAA&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Octasa 400mg MR gastro-resistant tablets : 1713</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=13T&amp;numIds=0105010B0BIACBD&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Octasa 1600mg MR gastro-resistant tablets : 12</a></li></ul></td></tr></tbody></table>
        </div>
      </div>
    </section>

    <script
      crossorigin="anonymous"
      integrity="sha512-pax4MlgXjHEPfCwcJLQhigY7+N8rt6bVvWLFyUMuxShv170X53TRzGPmPkZmGBhk+jikR8WBM4yl7A9WMHHqvg=="
      referrerpolicy="no-referrer"
      src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap/5.1.3/js/bootstrap.bundle.min.js"
    ></script>
    <script>
      var tooltipTriggerList = [].slice.call(
        document.querySelectorAll('[data-bs-toggle="tooltip"]')
      );
      var tooltipList = tooltipTriggerList.map(function (tooltipTriggerEl) {
        return new bootstrap.Tooltip(tooltipTriggerEl);
      });
    </script>
</body>

</html>